Skip to content

the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal Shock

The Effect of Oral Midodrine Versus Oral Desmopressin Acetate Use for Liberation From IV Noradrenaline in Intensive Care Unit Patients Recovering From Spinal Shock .

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04586790
Enrollment
90
Registered
2020-10-14
Start date
2020-10-15
Completion date
2021-01-28
Last updated
2020-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Shock

Brief summary

the study is developed to evaluate the effect of use of oral vasopressors (midodrine versus minirin) on weaning ICU patients from IV vasopressors (noradrenaline) and compare between them for efficacy in shortage the duration of IV vasopressor and has low complications and side effects.

Interventions

midodrine group will receive midodrine 10 mg PO q 8 hr with gradual weaning of IV nor-adrenaline after receiving 4 doses of oral midodrine .

DRUGMinirin oral tablet

Minirin group will receive minirin 60 µg PO q 8 hr with gradual weaning of IV nor-adrenaline after receiving 4 doses of oral minirin .

DRUGNor-Adrenaline

control group will receive IV nor-adrenaline and is gradually weaning from it according to routine hospital care without adding oral midodrine or oral minirin .

Sponsors

Ahmed talaat ahmed aly
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age of 18 - 60 years. * Patients of both genders. * Patients diagnosed by spinal shock and they are in the recovery stage .

Exclusion criteria

* Patient refusal. * Anuric or oliguric patients or patients with chronic kidney disease. * Patients with allergy to medication included in the study.

Design outcomes

Primary

MeasureTime frameDescription
liberation the patient from IV vasopressors with maintaining hemodynamics.48 hrsBlood pressure will be assessed regularly every 15 minutes

Countries

Egypt

Contacts

Primary ContactAhmed T Ahmed, lecture
Ahmedtalaat_ahmed@yahoo.com01062716629
Backup ContactAmal A Mohamed
amalabdelnasser28@gmail.com0102 175 9992

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026